WHO ICTRP trial
ASP II (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A…
EUCTR2005-006067-31-CZ · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2005-006067-31-CZ |
|---|---|
| Public title | ASP II (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment within 6 Hours of the Onset of Acute Ischemic Stroke |
| Scientific title | ASP II (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment within 6 Hours of the Onset of Acute Ischemic Stroke |
| Primary sponsor | Neurobiological Technologies Inc |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Slovakia;Czech Republic;Austria |
| Conditions | Acute Ischemic Stroke |
| Interventions | Product Name: Ancrod (Viprinex™) Pharmaceutical Form: Solution for injection INN or Proposed INN: Ancrod Other descriptive name: Arvin, Arwin, Lukrod Concentration unit: IU/ml international unit(s)/millilitre Concentration type: equal… |
| Registration date | May 22, 2006 |
| Target size | 650 |
| Secondary IDs | NTI-ASP-0503 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: